SOMERVILLE, Mass. – This month, OpenBiome celebrated two notable milestones in its effort to expand safe access to fecal microbiota transplantation (FMT):
- OpenBiome partnered with its 1,000th clinical provider.
One thousand hospitals and clinics throughout all 50 states and 7 countries have partnered with OpenBiome to provide life-saving FMT to patients with recurrent C. difficile infections.
- OpenBiome shipped out its 30,000th treatment.
Thanks to all of the stool donors who have served over the years, on December 18, 2017, we processed and shipped our 30,000th FMT preparation for a C. difficile patient in need of care.
More than half a million Americans of all ages contract C. difficile infections each year, making it the most common hospital-acquired infection in the country. One in five patients don’t respond to an initial course of antibiotics. For patients that have failed multiple rounds of treatment, FMT has a demonstrated cure rate of 85%, and has emerged in many institutions as the standard of care for patients with recurrent C. difficile infections.